Author: Teddy Lyons
New Pick: A Biotech Startup on the Verge of Curing Cancer
Cancer sucks. Everyone knows someone who has been affected by this deadly disease. And while treatment has come a long way, there is still no cure. The disease kills more than 600,000 people in the United States every year. Billions of dollars have been poured into cancer drug development for decades… but to no avail. Oncolyze, the anti-cancer biotech startup I’m introducing to you today, has some of the most promising efficacy data that…
Monogram Orthopaedics Announces an IPO
By Teddy Lyons on April 27, 2023
Pureboost Sales Hit Double-Digit Growth Despite Some Setbacks
By Teddy Lyons on April 6, 2023
New Pick: Invest in the Future of Sports Coaching
By Teddy Lyons on March 30, 2023
Portfolio Update: TÖST Expands Its Global Reach With Rave Reviews
By Teddy Lyons on January 26, 2023
SampleServe Is on the Brink of Major Growth
By Teddy Lyons on January 5, 2023
Barrow’s Intense Bounces Back From COVID-19 Troubles
By Teddy Lyons on November 10, 2022
Portfolio Update: Monogram Orthopaedics Explores a Public Listing
By Teddy Lyons on August 18, 2022
Smart Soda Gets $3 Million and a Huge Vote of Confidence
By Teddy Lyons on August 4, 2022
Blendid Makes Splendid Progress
By Teddy Lyons on July 21, 2022